This inventor holds 1 USPTO granted patent. Top assignee: Dupont Pharmaceuticals Company. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Randall K Ward
Introduction
Randall K Ward is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that target platelet aggregation.
Latest Patents
One of his key patents is for Crystalline Roxifiban. This potent platelet glycoprotein IIb/IIIa antagonist is produced in crystalline form. Crystalline Roxifiban exists in two polymorphic forms, designated Form 1 and Form 2. These polymorphic forms are characterized by x-ray powder diffraction and solid-state carbon NMR. The patent describes pharmaceutical compositions and methods for the treatment or prevention of diseases mediated by platelet aggregation.
Career Highlights
Randall K Ward is associated with DuPont Pharmaceuticals Company, where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating effective treatments that address critical health issues related to platelet function.
Collaborations
He has collaborated with notable colleagues, including Michael B Maurin and Philip Ma, to further enhance the impact of his research and innovations.
Conclusion
Randall K Ward's contributions to the field of pharmaceuticals, particularly through his patent on Crystalline Roxifiban, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.